Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
スポンサーリンク
概要
- 論文の詳細を見る
- 2001-02-28
著者
-
TANIGAWARA Yusuke
Department of Pharmacy, School of Medicine, Keio University
-
MINAMI Hironobu
Division of Oncology and Hematology, National Cancer Center Hospital East
-
ITOH Kuniaki
Division of Oncology and Hematology, National Cancer Center Hospital East
-
Minami H
Medical Oncology Department Of Medicine Kobe University Hospital And Graduate School Of Medicine
-
Minami Hironobu
神戸大学 医学研究科腫瘍内科学
-
Minami Hironobu
名古屋第一赤十字病院
-
Minami Hironobu
National Cancer Center Hospital East
-
Aizawa Tetsushi
Tochigi Cancer Center
-
OHTSU Tomoko
Amgen Limited
-
OHTSU Tomoko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
FUJII Hirofumi
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
IGARASHI Tadahiko
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
UCHIYAMA-KOKUBU Noriko
Tsukuba Research Institute, Novartis Pharma K.K.,
-
AIZAWA Tetsushi
Tsukuba Research Institute, Novartis Pharma K.K.,
-
WATANABE Toru
Tsukuba Research Institute, Novartis Pharma K.K.,
-
UDA Yoshinori
Tsukuba Research Institute, Novartis Pharma K.K.,
-
SASAKI Yasutsuna
Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi T
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Igarashi Tadahiko
神戸大学 医学研究科腫瘍内科学
-
Igarashi Tadahiko
国立がんセンター東病院
-
Igarashi Tadahiko
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa Kenichi
国立がんセンター東病院
-
WATANABE Toru
National Cancer Center Hospital
-
Minami H
Department Of Hematology Fujita Health University School Of Medicine
-
Mukai Hirofumi
国立がんセンター東病院 化学療法科血液
-
Itoh Kuniaki
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Fujii H
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Mukai Hirofumi
National Cancer Center Hospital East Oncology/hematology
-
Minami Hironobu
The Division Of Oncology/hematology National Cancer Center Hospital East
-
Minami Hironobu
Oncology/hematology National Cancer Center Hospital East
-
Tanigawara Yusuke
Department Of Hospital Pharmacy Keio University School Of Medicine
-
Tanigawara Yusuke
Department Of Clinical Pharmacokinetics And Pharmacodynamics School Of Medicine Keio University
-
Watanabe T
Tokyo Univ. Tokyo
-
Ohtsu Tomoko
Amgen Kk
-
Sasaki Yasutsuna
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Fujii Hirofumi
Division Of Hematology/oncology Beth Israel Deaconess Medical Center
-
Watanabe T
Department Of Pathology Gifu University School Of Medicine
-
Fujii Hideji
Research Laboratories Pharmaceuticals Group Nippon Kayaku Co. Ltd.
-
Mitsuya Hiroaki
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Minami Hironobu
National Cancer Center Hospital East Oncology/hematology
-
Ohtsu Tomoko
Division Of Oncology/hematology National Cancer Center Hospital East
-
Itoh Kuniaki
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Uda Yoshinori
Tsukuba Research Institute Novartis Pharma K.k.
-
Uchiyama-kokubu Noriko
Tsukuba Research Institute Novartis Pharma K.k.
-
Mukai Hirofumi
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Sasaki Yasutsuna
Division Of Hematology And Oncology National Cancer Center Hospital East
-
Watanabe Toru
Hematology And Stem Cell Transplantation Division National Cancer Center Hospital
-
Takahashi Isao
Second Department Of Internal Medicine Okayama University Medical School
-
Minami Hironobu
Division Of Medical Oncology/hematology Department Of Medicine Kobe University Graduate School Of Me
-
Watanabe Toru
Tsukuba Research Institute Novartis Pharma K.k.
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
Ohtsu Tomoko
Division of Hematology and Oncology, National Cancer Center Hospital East
関連論文
- 高血圧症患者におけるオルメサルタン及びアゼルニジピンの比較薬力学 : 母集団薬物動態 / 薬力学解析
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- S22-3 Pharmaco-proteomics and metabolomics for personalized medicine(FIP joint conference S22 International Conference Supported by FIP and JSPHCS Individualized Medicine: Bridging between Scientific and Clinical Studies)
- Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
- Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Genetic Polymorphisms of UGT1A6 in a Japanese Population
- Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
- Three Novel Single Nucleotide Polymorphisms in UGT1A9
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Three novel single nucleotide polymorphisms in UGT1A10
- Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
- A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
- MEAN RESIDENCE TIME IN ORGANS IN TOXICOKINETIC STUDIES
- Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- 健康成人における塩酸ランジオロールの母集団薬物動態モデルの構築
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Reversal Effects of Ca2+ Antagonists on Multidrug Resistance via Down-regulation of MDR1 mRNA
- A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- A Randomized Controlled Trial Investigating the Survival Benefit of Dose-Intensified Multidrug Combination Chemotherapy (LSG9) for Intermediate- or High-Grade Non-Hodgkin's Lymphoma : Japan Clinical Oncology Group Study 9002
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients
- Stereoscopic Scintigraphic Imaging of Breast Cancer Sentinel Lymph Nodes
- Single-institute phase 2 study of thalidomide treatment for refractory or relapsed multiple myeloma : Prognostic factors and unique toxicity profile
- Effect of axitinib (AG-013736) on fatigue, thyroid-stimulating hormone, and biomarkers : A phase I study in Japanese patients
- MDR1-Mediated Interaction of Digoxin with Antiarrhythmic or Antianginal Drugs
- Factors Influencing the Prediction of Steady State Concentrations of Digoxin
- Interaction of Docetaxel ("Taxotere") with Human P-Glycoprotein
- Cellular Pharmacokinetic Aspects of Reversal Effect of Itraconazole on P-Glycoprotein-Mediated Resistance of Anticancer Drugs
- Inhibitory Effects of a Cyclosporin Derivative, SDZ PSC 833, on Transport of Doxorubicin and Vinblastine via Human P-Glycoprotein
- Thalidomide for the Treatment of Refractory Multiple Myeloma : Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- N-Acetyltransferase2 Genotype Correlated with Isoniazid Acetylation in Japanese Tuberculous Patients
- Effects of Secretable SOD Delivered by Genetically Modified Cells on Xanthine/Xanthine Oxidase and Paraquat-Induced Cytotoxicity in Vitro
- Effects of Cu, Zn-Superoxide Dismutase Delivered by Genetically Modified Skin Fibroblasts on Cold-Induced Skin Edema in Rats
- Effect of Transfection with a Superoxide Dismutase Expression Plasmid on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Cultured Rat Lung Cells
- Pharmaceutical Studies for Gene Therapy : Expression of Human Cu, Zn-Superoxide Dismutase Gene Transfected by Lipofection in Rat Skin Fibroblasts
- Effect of Transfection with Superoxide Dismutase Expression Plasmid on Superoxide Anion Induced Cytotoxicity in Cultured Rat Lung Cells
- Pharmacodynamic analysis of vancomycin effect alone and with serum proteins : using a novel in vitro model
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
- Sufficient effect of 1-week omeprazole and amoxicillin dual treatment for Helicobacter pylori eradication in cytochrome P450 2C19 poor metabolizers
- ミカファンギンの小児適応のためのポピュレーションPK解析
- Linear Pharmacokinetics of Micafungin and Its Active Metabolites in Japanese Pediatric Patients with Fungal Infections(Biopharmacy)
- A novel proteomic approach to determine possible biomarkers for acute rejection after small bowel transplantation
- Discovery of new biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat liver transplantation : a comprehensive gene expression analysis
- Oblique view of preoperative lymphoscintigraphy improves detection of sentinel lymph nodes in esophageal cancer
- A major influence of CYP2C19 genotype on the steady-state concentration of N-desmethylclobazam
- Influence of N-Terminal Peptide and Oligosaccharide on the Clearance of t-PA
- Intracellular Levels of Two Cyclosporin Derivatives Valspodar (PSC 883) and Cyclosporin A Closely Associated with Multidrug Resistance-modulating Activity in Sublines of Human Colorectal Adenocarcinoma HCT-15
- Prognostic Factors for Short-term Survival in Patients with Stage IV Non-small Cell Lung Cancer
- Pharmacokinetic Study of Carboplatin Given on a 5-Day Intravenous Schedule
- Therapeutic Drug Monitoring in 21-Day Oral Etoposide Treatment for Lung Cancer
- Therapeutic Drug Monitoring of Etoposide in a 14-Day Infusion for Non-small-cell Lung Cancer
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Pharmacodynamic Modeling of the Entire Time Course of Leukopenia after a 3-Hour Infusion of Paclitaxel
- The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P-Glycoprotein
- Influence of Sugar Chain on Fibrin Affinity of Recombinat t-PA
- New biomarkers for acute rejection and therapeutic effect of immunosuppressive drugs in the rat cardiac transplantation by cDNA microarray analysis
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- Relationship between Pharmacokinetic Parameters and Occurrence of Adverse Events in Clinical Trials Performed in Europe and United States for an Angiotensin II Receptor Antagonist, Telmisartan
- Pharmacokinetic Comparison of an Angiotensin II Receptor Antagonist, Telmisartan, in Japanese and Western Hypertensive Patients Using Population Pharmacokinetic Method
- Cardiac safety of trastuzumab as adjuvant treatment for Japanese patients with early breast cancer
- Phorbol Myristate Acetate Stimulates Degradation of a Structural Analogue of Platelet-Activating Factor to a Neutral Lipid in Human Leukemic K562 Cells : Relevance to the Release of Lipids(Biochemistry/Molecular Biology)
- Prediction of the efficacy and safety of pioglitazone in patients with type 2 diabetes mellitus
- Occult Thymic Carcinoma Presenting as Malignant Cardiac Tamponade
- Serum cystatin C as a new marker for determining the optimal dosage of renally excreted drugs
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Review of primary unknown cancer : cases referred to the National Cancer Center Hospital East
- Phase I dose escalation and pharmacokinetic study of oral enzastaurin (LY317615) in advanced solid tumors
- Modulation of Multidrug Resistance by SDZ PSC 833 in Leukemic and Solid-tumor-bearing Mouse Models
- Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
- Successful neutrophil engraftment by reduced use of granulocyte colony-stimulating factor after allogeneic hematopoietic stem cell transplantation with mycophenolate mofetil for graft-versus-host disease prophylaxis